Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Promising early results for escitalopram in treatment of kleptomania

Sep. 28, 2004

Long-term clinical evaluation of three treatments for early PD

Sep. 28, 2004

Clinical trials confirm the efficacy of ropinirole in PD and RLS

Sep. 28, 2004

RGH-896 demonstrates in vivo analgesia

Sep. 28, 2004

New perspectives in the use of sumatriptan to treat migraine

Sep. 28, 2004

Merck KGaA grants vilazodone rights to Genaissance

Sep. 28, 2004

Novartis presents new cathepsin S inhibitors with utility in neuropathic pain

Sep. 28, 2004

AF-3191 effective in preclinical pain models

Sep. 27, 2004

GW-274150 reduces experimental neuropathic hypersensitivity

Sep. 27, 2004

In vivo effects of capsaicin reduced by GW-833972

Sep. 27, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...